ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

ClinicalTrials.gov ID: NCT01681121

Public ClinicalTrials.gov record NCT01681121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy

Study identification

NCT ID
NCT01681121
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
93 participants

Conditions and interventions

Conditions

Interventions

  • ADX-N05 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2012
Primary completion
Jul 31, 2013
Completion
Jul 31, 2013
Last update posted
May 27, 2021

2012 – 2013

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Sleep Disorders Center of Alabama Birmingham Alabama 35213
Pulmonary Associates Phoenix Arizona 85006
Stanford Sleep Medicine Center Redwood City California 94063
Pacific Research Network San Diego California 92103
Sleep-Alertness Disorders Center Aurora Colorado 80012
PAB Clinical Research Brandon Florida 33511
Clinical Research Group of St. Petersburg St. Petersburg Florida 33707
NeuroTrials Research, Inc. Atlanta Georgia 30342
Sleep Disorders Center of Georgia Atlanta Georgia 30342
SleepMed of Central Georgia Macon Georgia 31201
Chicago Research Center Chicago Illinois 60634
Community Research Crestview Hills Kentucky 41017
Kentucky Research Group Louisville Kentucky 40217
The Center for Sleep and Wake Disorders Chevy Chase Maryland 20815
Pulmonary and Critical Care Associates of Baltimore Towson Maryland 21204
Neurocare, Inc. Newton Massachusetts 02459
Minnesota Lung Center and Sleep Institute Edina Minnesota 55435
Washington University St Louis Missouri 63108
Rex Sleep Disorders Center Raleigh North Carolina 27607
Wake Research Associates Raleigh North Carolina 27612
Mercy St. Vincent Medical Center Toledo Ohio 43623
Center for Sleep Medicine Philadelphia Pennsylvania 19118
SleepMed of South Carolina Columbia South Carolina 29201
Future Search Trials of Neurology Austin Texas 78731
Sleep Medicine Associates of Texas Dallas Texas 75231
Todd J. Swick, MD, PA Houston Texas 77063
Metroplex Pulmonary and Sleep Center McKinney Texas 75069
Sleep Therapy and Research Center San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01681121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 27, 2021 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01681121 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →